333 related articles for article (PubMed ID: 18606059)
1. [Antitumor effects and mechanisms of a dendritic cell vaccine which silenced SOCS1 by siRNA, stimulated by OK-432 and pulsed with lysate of HepG2 cells].
Song HF; Zhou J; Pan K; Wang QJ; Wang H; Huang LX; Li YQ; Xia JC
Ai Zheng; 2008 Jul; 27(7):685-91. PubMed ID: 18606059
[TBL] [Abstract][Full Text] [Related]
2. Effects of epidermal growth factor receptor fusion protein on the cytotoxic activity of SOCS1-silenced dendritic cells in vitro.
Jiang Q; Wang X; Qian M; Chen D; Xu Y
Oncol Rep; 2018 Mar; 39(3):1306-1312. PubMed ID: 29286121
[TBL] [Abstract][Full Text] [Related]
3. [Research of SOCS1 silent DC vaccine on laryngocarcinoma therapy].
Yuan Y; Wang XF; Zhang Y; Wang JY; Luan N
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Feb; 26(4):169-73. PubMed ID: 22568257
[TBL] [Abstract][Full Text] [Related]
4. [An in vitro study of specific antitumor immunity induced by dendritic cells pulsed with tumor cell lysates from patients with hepatocellular carcinoma].
Gao J; Chen M; Peng ML; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):198-201. PubMed ID: 15760555
[TBL] [Abstract][Full Text] [Related]
5. [Inhibiting effect of IL-10 in tumor microenvironment on anti-tumor activity of SOCS1-silenced DC vaccine].
Wang Z; You H; Song S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Apr; 29(4):379-83. PubMed ID: 23643168
[TBL] [Abstract][Full Text] [Related]
6. Induction of CML28-specific cytotoxic T cell responses using co-transfected dendritic cells with CML28 DNA vaccine and SOCS1 small interfering RNA expression vector.
Zhou H; Zhang D; Wang Y; Dai M; Zhang L; Liu W; Liu D; Tan H; Huang Z
Biochem Biophys Res Commun; 2006 Aug; 347(1):200-7. PubMed ID: 16815301
[TBL] [Abstract][Full Text] [Related]
7. Silenced suppressor of cytokine signaling 1 (SOCS1) enhances the maturation and antifungal immunity of dendritic cells in response to Candida albicans in vitro.
Shi D; Li D; Yin Q; Qiu Y; Yan H; Shen Y; Lu G; Liu W
Immunol Res; 2015 Mar; 61(3):206-18. PubMed ID: 25381480
[TBL] [Abstract][Full Text] [Related]
8. Antigen-loaded dendritic cells triggers a specific cytotoxic T lymphocytes immune response against hepatocellular carcinoma: in vitro study.
El-Ashmawy NE; El-Zamarany EA; Khedr EG; El-Bahrawy HA; El-Feky OA
Clin Transl Oncol; 2019 May; 21(5):636-645. PubMed ID: 30368725
[TBL] [Abstract][Full Text] [Related]
9. Enhanced immunotherapeutic effect of modified HPV16 E7-pulsed dendritic cell vaccine by an adeno-shRNA-SOCS1 virus.
Zhu Y; Zheng Y; Mei L; Liu M; Li S; Xiao H; Zhu H; Wu S; Chen H; Huang L
Int J Oncol; 2013 Oct; 43(4):1151-9. PubMed ID: 23877655
[TBL] [Abstract][Full Text] [Related]
10. [Primary study on preparation and efficiency of neotype hepatocellular carcinoma-dendritic cell vaccine with SOCS1 expression inhibited].
Liu ZP; Zhang J; Lin P; Wang XJ; Wang Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 39(2):177-80. PubMed ID: 18630677
[TBL] [Abstract][Full Text] [Related]
11. [In vitro anti-tumor effect of CTL induced by HSP70-Id complex-modified dendritic cells].
Wang ZH; Ye Q; Hu ZQ; Ye ZQ; Yu X; Shen GX
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):481-5. PubMed ID: 17147108
[TBL] [Abstract][Full Text] [Related]
12. Streptococcal preparation OK-432 promotes fusion efficiency and enhances induction of antigen-specific CTL by fusions of dendritic cells and colorectal cancer cells.
Koido S; Hara E; Homma S; Torii A; Mitsunaga M; Yanagisawa S; Toyama Y; Kawahara H; Watanabe M; Yoshida S; Kobayashi S; Yanaga K; Fujise K; Tajiri H
J Immunol; 2007 Jan; 178(1):613-22. PubMed ID: 17182602
[TBL] [Abstract][Full Text] [Related]
13. A suppressor of cytokine signaling 1 antagonist enhances antigen-presenting capacity and tumor cell antigen-specific cytotoxic T lymphocyte responses by human monocyte-derived dendritic cells.
Wang Y; Wang S; Ding Y; Ye Y; Xu Y; He H; Li Q; Mi Y; Guo C; Lin Z; Liu T; Zhang Y; Chen Y; Yan J
Clin Vaccine Immunol; 2013 Sep; 20(9):1449-56. PubMed ID: 23885028
[TBL] [Abstract][Full Text] [Related]
14. Streptococcal preparation OK-432 promotes the capacity of dendritic cells (DCs) to prime carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocyte responses induced with genetically modified DCs that express CEA.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Katsuda M; Miyazawa M; Iida T; Yamaue H
Int J Oncol; 2008 Feb; 32(2):459-66. PubMed ID: 18202769
[TBL] [Abstract][Full Text] [Related]
15. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines.
Schnurr M; Galambos P; Scholz C; Then F; Dauer M; Endres S; Eigler A
Cancer Res; 2001 Sep; 61(17):6445-50. PubMed ID: 11522639
[TBL] [Abstract][Full Text] [Related]
16. Improved efficacy of therapeutic vaccination with dendritic cells pulsed with tumor cell lysate against hepatocellular carcinoma by introduction of 2 tandem repeats of microbial HSP70 peptide epitope 407-426 and OK-432.
Ge C; Xing Y; Wang Q; Xiao W; Lu Y; Hu X; Gao Z; Xu M; Ma Y; Cao R; Liu J
Int Immunopharmacol; 2011 Dec; 11(12):2200-7. PubMed ID: 22015603
[TBL] [Abstract][Full Text] [Related]
17. [Silencing of SOCS1 and IL-12 gene cotransferred by adenoviral enhances DC-mediated anti-laryngocarcinoma immunity in vitro].
Li Y; Yuan Y; Wang X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 26(19):890-2, 896. PubMed ID: 23285955
[TBL] [Abstract][Full Text] [Related]
18. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
[TBL] [Abstract][Full Text] [Related]
19. [Generation of T cell-mediated antitumor response in vitro by autologous dendritic cells pulsed with tumor lysates in patients with non-small cell lung cancer].
You J; Yu JP; Ren XB; Wang CL; Zhang P; Zhang XZ
Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):333-6. PubMed ID: 15312341
[TBL] [Abstract][Full Text] [Related]
20. Enhanced induction of HIV-specific cytotoxic T lymphocytes by dendritic cell-targeted delivery of SOCS-1 siRNA.
Subramanya S; Armant M; Salkowitz JR; Nyakeriga AM; Haridas V; Hasan M; Bansal A; Goepfert PA; Wynn KK; Ladell K; Price DA; N M; Kan-Mitchell J; Shankar P
Mol Ther; 2010 Nov; 18(11):2028-37. PubMed ID: 20648001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
